| scholarly article | Q13442814 |
| P50 | author | Weibo Cai | Q87755256 |
| Charles P Theuer | Q117270658 | ||
| Todd E. Barnhart | Q55206507 | ||
| Jonathan W. Engle | Q59696018 | ||
| P2093 | author name string | Yin Zhang | |
| Hao Hong | |||
| Hector F Valdovinos | |||
| Robert J Nickles | |||
| Duane V Myklejord | |||
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| Human immunoglobulin allotypes: possible implications for immunogenicity | Q24651893 | ||
| Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide | Q28203483 | ||
| Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels | Q28207513 | ||
| Positron emission tomography (PET) imaging with (18)F-based radiotracers | Q28716029 | ||
| Positron emission tomography imaging of CD105 expression with a 64Cu-labeled monoclonal antibody: NOTA is superior to DOTA | Q28741667 | ||
| Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review | Q29617388 | ||
| Cerenkov luminescence imaging of medical isotopes | Q30499280 | ||
| A tabulated summary of the FDG PET literature. | Q34325136 | ||
| Tumor angiogenic marker expression levels during tumor growth: longitudinal assessment with molecularly targeted microbubbles and US imaging | Q34591102 | ||
| Positron emission tomography imaging of CD105 expression during tumor angiogenesis. | Q35017120 | ||
| Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma | Q35088308 | ||
| In vivo near-infrared fluorescence imaging of CD105 expression during tumor angiogenesis | Q35291271 | ||
| Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105. | Q35587248 | ||
| Positron Emission Tomography and Near-Infrared Fluorescence Imaging of Vascular Endothelial Growth Factor with Dual-Labeled Bevacizumab | Q35646547 | ||
| Positron emission tomography and optical imaging of tumor CD105 expression with a dual-labeled monoclonal antibody. | Q35809541 | ||
| Very high specific activity ⁶⁶/⁶⁸Ga from zinc targets for PET. | Q36087168 | ||
| Cetuximab | Q36166138 | ||
| Peptoid-based PET imaging of vascular endothelial growth factor receptor (VEGFR) expression. | Q36337218 | ||
| (18)F-FDG PET in sarcoma treatment response imaging. | Q36337223 | ||
| How to study optimal timing of PET/CT for monitoring of cancer treatment | Q36337232 | ||
| FcRn: the neonatal Fc receptor comes of age. | Q36912134 | ||
| Endoglin (CD105): a marker of tumor vasculature and potential target for therapy | Q37125562 | ||
| Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours | Q37610628 | ||
| Endoglin-Targeted Cancer Therapy | Q37804900 | ||
| Positron emitting [68Ga]Ga-based imaging agents: chemistry and diversity | Q37895281 | ||
| PET tracers based on Zirconium-89. | Q37970745 | ||
| The clinical use of PET with (11)C-acetate. | Q38058333 | ||
| Cerenkov imaging - a new modality for molecular imaging | Q38058334 | ||
| Development of NGR peptide-based agents for tumor imaging | Q39799588 | ||
| Quantitative radioimmunoPET imaging of EphA2 in tumor-bearing mice | Q40098498 | ||
| Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature | Q40187867 | ||
| PET of vascular endothelial growth factor receptor expression. | Q40202359 | ||
| In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3. | Q40223991 | ||
| Endoglin is a suitable target for efficient imaging of solid tumors: in vivo evidence in a canine mammary carcinoma model | Q40879212 | ||
| Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors. | Q43873872 | ||
| Production and purification of gallium-66 for preparation of tumor-targeting radiopharmaceuticals | Q44138125 | ||
| Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals | Q44589883 | ||
| Direct separation of 67Ga citrate from zinc and copper target materials by anion exchange | Q44658781 | ||
| Image-quality assessment for several positron emitters using the NEMA NU 4-2008 standards in the Siemens Inveon small-animal PET scanner. | Q51713152 | ||
| An investigation of the physical characteristics of 66Ga as an isotope for PET imaging and quantification | Q73106379 | ||
| Imaging of tumour neovasculature by targeting the TGF-beta binding receptor endoglin | Q73594909 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | positron emission tomography | Q208376 |
| monoclonal antibody | Q422248 | ||
| tumor angiogenesis | Q110495869 | ||
| P304 | page(s) | 1441-1448 | |
| P577 | publication date | 2012-04-21 | |
| P1433 | published in | Molecular Pharmaceutics | Q3011140 |
| P1476 | title | Positron emission tomography imaging of tumor angiogenesis with a 66Ga-labeled monoclonal antibody | |
| P478 | volume | 9 |
| Q88771433 | 86/90Y-Based Theranostics Targeting Angiogenesis in a Murine Breast Cancer Model |
| Q34662173 | A novel 99mTc-labeled molecular probe for tumor angiogenesis imaging in hepatoma xenografts model: a pilot study |
| Q30759992 | Dynamic Positron Emission Tomography Imaging of Renal Clearable Gold Nanoparticles. |
| Q52676734 | Efficient targeted tumor imaging and secreted endostatin gene delivery by anti-CD105 immunoliposomes. |
| Q57291441 | Ga: A Novelty or a Valuable Preclinical Screening Tool for the Design of Targeted Radiopharmaceuticals? |
| Q90581932 | ImmunoPET: Concept, Design, and Applications |
| Q37624855 | Intraoperative targeted optical imaging: a guide towards tumor-free margins in cancer surgery |
| Q26824070 | Mapping biological behaviors by application of longer-lived positron emitting radionuclides |
| Q28391928 | Novel Preparation Methods of (52)Mn for ImmunoPET Imaging |
| Q48228929 | PET Radiometals for Antibody Labeling. |
| Q34464099 | PET/SPECT imaging of hindlimb ischemia: focusing on angiogenesis and blood flow |
| Q34759659 | Positron emission tomography imaging of angiogenesis in a murine hindlimb ischemia model with 64Cu-labeled TRC105 |
| Q37689802 | Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy |
| Q47447811 | Radiolabeled, Antibody-Conjugated Manganese Oxide Nanoparticles for Tumor Vasculature Targeted Positron Emission Tomography and Magnetic Resonance Imaging |
| Q35079462 | Red fluorescent zinc oxide nanoparticle: a novel platform for cancer targeting. |
| Q34178035 | Theranostic unimolecular micelles based on brush-shaped amphiphilic block copolymers for tumor-targeted drug delivery and positron emission tomography imaging |
| Q38261959 | Vectors for the delivery of radiopharmaceuticals in cancer therapeutics |
Search more.